-
1
-
-
13644269309
-
Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia
-
American Thoracic Society
-
American Thoracic Society. 2005. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 171:388-416.
-
(2005)
Am. J. Respir. Crit. Care Med.
, vol.171
, pp. 388-416
-
-
-
2
-
-
0035178825
-
Development of vancomycin and lysostaphin resistance in a methicillin-resistant Staphylococcus aureus isolate
-
Boyle-Vavra, S., R. B. Carey, and R. S. Daum. 2001. Development of vancomycin and lysostaphin resistance in a methicillin-resistant Staphylococcus aureus isolate. J. Antimicrob. Chemother. 48:617-625.
-
(2001)
J. Antimicrob. Chemother.
, vol.48
, pp. 617-625
-
-
Boyle-Vavra, S.1
Carey, R.B.2
Daum, R.S.3
-
3
-
-
0037417230
-
Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene
-
Chang, S., D. M. Sievert, J. C. Hageman, M. L. Boulton, F. C. Tenover, F. P. Downes, S. Shah, J. T. Rudrik, G. R. Pupp, W. J. Brown, D. Cardo, and S. K. Fridkin. 2003. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N. Engl. J. Med. 348:1342-1347.
-
(2003)
N. Engl. J. Med.
, vol.348
, pp. 1342-1347
-
-
Chang, S.1
Sievert, D.M.2
Hageman, J.C.3
Boulton, M.L.4
Tenover, F.C.5
Downes, F.P.6
Shah, S.7
Rudrik, J.T.8
Pupp, G.R.9
Brown, W.J.10
Cardo, D.11
Fridkin, S.K.12
-
4
-
-
33748677949
-
Mechanism-based pharmacodynamic models of fluoroquinolone resistance in Staphylococcus aureus
-
Chung, P., P. J. McNamara, J. J. Campion, and M. E. Evans. 2006. Mechanism-based pharmacodynamic models of fluoroquinolone resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 50:2957-2965.
-
(2006)
Antimicrob. Agents Chemother.
, vol.50
, pp. 2957-2965
-
-
Chung, P.1
McNamara, P.J.2
Campion, J.J.3
Evans, M.E.4
-
5
-
-
0029803527
-
Penetration of vancomycin into human lung tissue
-
Cruciani, M., G. Gatti, L. Lazzarini, G. Furlan, G. Broccali, M. Malena, C. Franchini, and E. Concia. 1996. Penetration of vancomycin into human lung tissue. J. Antimicrob. Chemother. 38:865-869.
-
(1996)
J. Antimicrob. Chemother.
, vol.38
, pp. 865-869
-
-
Cruciani, M.1
Gatti, G.2
Lazzarini, L.3
Furlan, G.4
Broccali, G.5
Malena, M.6
Franchini, C.7
Concia, E.8
-
6
-
-
31944435626
-
Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus
-
Cui, L., A. Iwamoto, J. Q. Lian, H. M. Neoh, T. Maruyama, Y. Horikawa, and K. Hiramatsu. 2006. Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus. Antimicrob. Agents Chemother. 50:428-438.
-
(2006)
Antimicrob. Agents Chemother.
, vol.50
, pp. 428-438
-
-
Cui, L.1
Iwamoto, A.2
Lian, J.Q.3
Neoh, H.M.4
Maruyama, T.5
Horikawa, Y.6
Hiramatsu, K.7
-
7
-
-
0030782631
-
Pharmacokinetic-pharmacodynamic modelling of the in vitro antiinfective effect of piperacillin-tazobactam combinations
-
Dalla Costa, T., A. Nolting, K. Rand, and H. Derendorf. 1997. Pharmacokinetic-pharmacodynamic modelling of the in vitro antiinfective effect of piperacillin-tazobactam combinations. Int. J. Clin. Pharmacol. Ther. 35:426-433.
-
(1997)
Int. J. Clin. Pharmacol. Ther.
, vol.35
, pp. 426-433
-
-
Dalla Costa, T.1
Nolting, A.2
Rand, K.3
Derendorf, H.4
-
8
-
-
70349145359
-
Penetration of vancomycin (V) into epithelial lining fluid (ELF)
-
Abstr. abstr. A-11
-
Drusano, G. L., C. M. Rubino, P. G. Ambrose, S. M. Bhavnani, A. Forrest, A. Louie, M. Gotfried, and K. A. Rodvold. Penetration of vancomycin (V) into epithelial lining fluid (ELF). Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother., abstr. A-11.
-
47th Intersci. Conf. Antimicrob. Agents Chemother.
-
-
Drusano, G.L.1
Rubino, C.M.2
Ambrose, P.G.3
Bhavnani, S.M.4
Forrest, A.5
Louie, A.6
Gotfried, M.7
Rodvold, K.A.8
-
9
-
-
6944234949
-
Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling
-
Gumbo, T., A. Louie, M. R. Deziel, L. M. Parsons, M. Salfinger, and G. L. Drusano. 2004. Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling. J. Infect. Dis. 190:1642-1651.
-
(2004)
J. Infect. Dis.
, vol.190
, pp. 1642-1651
-
-
Gumbo, T.1
Louie, A.2
Deziel, M.R.3
Parsons, L.M.4
Salfinger, M.5
Drusano, G.L.6
-
10
-
-
33750285524
-
High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: Efficacy and toxicity
-
Hidayat, L. K., D. I. Hsu, R. Quist, K. A. Shriner, and A. Wong-Beringer. 2006. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch. Intern. Med. 166: 2138-2144.
-
(2006)
Arch. Intern. Med.
, vol.166
, pp. 2138-2144
-
-
Hidayat, L.K.1
Hsu, D.I.2
Quist, R.3
Shriner, K.A.4
Wong-Beringer, A.5
-
11
-
-
0031566835
-
Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin
-
DOI 10.1016/S0140-6736(97)07324-8
-
Hiramatsu, K., N. Aritaka, H. Hanaki, S. Kawasaki, Y. Hosoda, S. Hori, Y. Fukuchi, and I. Kobayashi. 1997. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350:1670-1673. (Pubitemid 28036828)
-
(1997)
Lancet
, vol.350
, Issue.9092
, pp. 1670-1673
-
-
Hiramatsu, K.1
Aritaka, N.2
Hanaki, H.3
Kawasaki, S.4
Hosoda, Y.5
Hori, S.6
Fukuchi, Y.7
Kobayashi, I.8
-
12
-
-
33750082642
-
Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: Specific evaluation of vancomycin pharmacokinetic indices
-
Jeffres, M. N., W. Isakow, J. A. Doherty, P. S. McKinnon, D. J. Ritchie, S. T. Micek, and M. H. Kollef. 2006. Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices. Chest 130:947-955.
-
(2006)
Chest
, vol.130
, pp. 947-955
-
-
Jeffres, M.N.1
Isakow, W.2
Doherty, J.A.3
McKinnon, P.S.4
Ritchie, D.J.5
Micek, S.T.6
Kollef, M.H.7
-
13
-
-
34547686271
-
A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia
-
Jeffres, M. N., W. Isakow, J. A. Doherty, S. T. Micek, and M. H. Kollef. 2007. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia. Clin. Ther. 29:1107-1115.
-
(2007)
Clin. Ther.
, vol.29
, pp. 1107-1115
-
-
Jeffres, M.N.1
Isakow, W.2
Doherty, J.A.3
Micek, S.T.4
Kollef, M.H.5
-
14
-
-
0030838740
-
Bacterial interference caused by autoinducing peptide variants
-
DOI 10.1126/science.276.5321.2027
-
Ji, G., R. Beavis, and R. P. Novick. 1997. Bacterial interference caused by autoinducing peptide variants. Science 276:2027-2030. (Pubitemid 27443604)
-
(1997)
Science
, vol.276
, Issue.5321
, pp. 2027-2030
-
-
Ji, G.1
Beavis, R.2
Novick, R.P.3
-
15
-
-
29244477534
-
Microbiological features of vancomycin in the 21st century: Minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains
-
Jones, R. N. 2006. Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains. Clin. Infect. Dis. 42(Suppl. 1):S13-S24.
-
(2006)
Clin. Infect. Dis.
, vol.42
, Issue.SUPPL. 1
-
-
Jones, R.N.1
-
16
-
-
0042743965
-
Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy
-
Jumbe, N., A. Louie, R. Leary, W. Liu, M. R. Deziel, V. H. Tam, R. Bachhawat, C. Freeman, J. B. Kahn, K. Bush, M. N. Dudley, M. H. Miller, and G. L. Drusano. 2003. Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy. J. Clin. Investig. 112:275-285.
-
(2003)
J. Clin. Investig.
, vol.112
, pp. 275-285
-
-
Jumbe, N.1
Louie, A.2
Leary, R.3
Liu, W.4
Deziel, M.R.5
Tam, V.H.6
Bachhawat, R.7
Freeman, C.8
Kahn, J.B.9
Bush, K.10
Dudley, M.N.11
Miller, M.H.12
Drusano, G.L.13
-
17
-
-
34548507204
-
Limitations of vancomycin in the management of resistant staphylococcal infections
-
Kollef, M. H. 2007. Limitations of vancomycin in the management of resistant staphylococcal infections. Clin. Infect. Dis. 45(Suppl. 3):S191-S195.
-
(2007)
Clin. Infect. Dis.
, vol.45
, Issue.SUPPL. 3
-
-
Kollef, M.H.1
-
18
-
-
0043166886
-
Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus
-
Kuroda, M., H. Kuroda, T. Oshima, F. Takeuchi, H. Mori, and K. Hiramatsu. 2003. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol. Microbiol. 49:807-821.
-
(2003)
Mol. Microbiol.
, vol.49
, pp. 807-821
-
-
Kuroda, M.1
Kuroda, H.2
Oshima, T.3
Takeuchi, F.4
Mori, H.5
Hiramatsu, K.6
-
19
-
-
0035925904
-
Whole genome sequencing of meticillin-resistant Staphylococcus aureus
-
DOI 10.1016/S0140-6736(00)04403-2
-
Kuroda, M., T. Ohta, I. Uchiyama, T. Baba, H. Yuzawa, I. Kobayashi, L. Cui, A. Oguchi, K. Aoki, Y. Nagai, J. Lian, T. Ito, M. Kanamori, H. Matsumaru, A. Maruyama, H. Murakami, A. Hosoyama, Y. Mizutani-Ui, N. K. Takahashi, T. Sawano, R. Inoue, C. Kaito, K. Sekimizu, H. Hirakawa, S. Kuhara, S. Goto, J. Yabuzaki, M. Kanehisa, A. Yamashita, K. Oshima, K. Furuya, C. Yoshino, T. Shiba, M. Hattori, N. Ogasawara, H. Hayashi, and K. Hiramatsu. 2001. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 357:1225-1240. (Pubitemid 32539050)
-
(2001)
Lancet
, vol.357
, Issue.9264
, pp. 1225-1240
-
-
Kuroda, M.1
Ohta, T.2
Uchiyama, I.3
Baba, T.4
Yuzawa, H.5
Kobayashi, I.6
Kobayashi, N.7
Cui, L.8
Oguchi, A.9
Aoki, K.-I.10
Nagai, Y.11
Lian, J.12
Ito, T.13
Kanamori, M.14
Matsumaru, H.15
Maruyama, A.16
Murakami, H.17
Hosoyama, A.18
Mizutani-Ui, Y.19
Takahashi, N.K.20
Sawano, T.21
Inoue, R.-I.22
Kaito, C.23
Sekimizu, K.24
Hirakawa, H.25
Kuhara, S.26
Goto, S.27
Yabuzaki, J.28
Kanehisa, M.29
Yamashita, A.30
Oshima, K.31
Furuya, K.32
Yoshino, C.33
Shiba, T.34
Hattori, M.35
Ogasawara, N.36
Hayashi, H.37
Hiramatsu, K.38
more..
-
20
-
-
0027499255
-
Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients
-
Lamer, C., V. de Beco, P. Soler, S. Calvat, J. Y. Fagon, M. C. Dombret, R. Farinotti, J. Chastre, and C. Gibert. 1993. Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients. Antimicrob. Agents Chemother. 37:281-286.
-
(1993)
Antimicrob. Agents Chemother.
, vol.37
, pp. 281-286
-
-
Lamer, C.1
De Beco, V.2
Soler, P.3
Calvat, S.4
Fagon, J.Y.5
Dombret, M.C.6
Farinotti, R.7
Chastre, J.8
Gibert, C.9
-
21
-
-
9644255765
-
Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model
-
LaPlante, K. L., and M. J. Rybak. 2004. Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model. Antimicrob. Agents Chemother. 48:4665-4672.
-
(2004)
Antimicrob. Agents Chemother.
, vol.48
, pp. 4665-4672
-
-
LaPlante, K.L.1
Rybak, M.J.2
-
23
-
-
0026047842
-
Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis
-
Levine, D. P., B. S. Fromm, and B. R. Reddy. 1991. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann. Intern. Med. 115:674-680.
-
(1991)
Ann. Intern. Med.
, vol.115
, pp. 674-680
-
-
Levine, D.P.1
Fromm, B.S.2
Reddy, B.R.3
-
24
-
-
42049113605
-
Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity
-
Lodise, T. P., B. Lomaestro, J. Graves, and G. L. Drusano. 2008. Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity. Antimicrob. Agents Chemother. 52: 1330-1336.
-
(2008)
Antimicrob. Agents Chemother.
, vol.52
, pp. 1330-1336
-
-
Lodise, T.P.1
Lomaestro, B.2
Graves, J.3
Drusano, G.L.4
-
25
-
-
67749147359
-
Pharmacodynamics of levofloxacin in a murine pneumonia model of Pseudomonas aeruginosa infection: Determination of epithelial lining fluid (ELF) targets
-
Louie, A., C. Fregeau, W. Liu, R. Kulawy, and G. L. Drusano. 2009. Pharmacodynamics of levofloxacin in a murine pneumonia model of Pseudomonas aeruginosa infection: determination of epithelial lining fluid (ELF) targets. Antimicrob. Agents Chemother. 53:3325-3330.
-
(2009)
Antimicrob. Agents Chemother.
, vol.53
, pp. 3325-3330
-
-
Louie, A.1
Fregeau, C.2
Liu, W.3
Kulawy, R.4
Drusano, G.L.5
-
26
-
-
2542482710
-
Novel pharmacokinetic-pharmacodynamic model for prediction of outcomes with an extended-release formulation of ciprofloxacin
-
Meagher, A. K., A. Forrest, A. Dalhoff, H. Stass, and J. J. Schentag. 2004. Novel pharmacokinetic-pharmacodynamic model for prediction of outcomes with an extended-release formulation of ciprofloxacin. Antimicrob. Agents Chemother. 48:2061-2068.
-
(2004)
Antimicrob. Agents Chemother.
, vol.48
, pp. 2061-2068
-
-
Meagher, A.K.1
Forrest, A.2
Dalhoff, A.3
Stass, H.4
Schentag, J.J.5
-
27
-
-
7444254040
-
Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections
-
Moise-Broder, P. A., A. Forrest, M. C. Birmingham, and J. J. Schentag. 2004. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin. Pharmacokinet. 43:925-942.
-
(2004)
Clin. Pharmacokinet.
, vol.43
, pp. 925-942
-
-
Moise-Broder, P.A.1
Forrest, A.2
Birmingham, M.C.3
Schentag, J.J.4
-
28
-
-
2942515665
-
Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy
-
Moise-Broder, P. A., G. Sakoulas, G. M. Eliopoulos, J. J. Schentag, A. Forrest, and R. C. Moellering, Jr. 2004. Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. Clin. Infect. Dis. 38:1700-1705.
-
(2004)
Clin. Infect. Dis.
, vol.38
, pp. 1700-1705
-
-
Moise-Broder, P.A.1
Sakoulas, G.2
Eliopoulos, G.M.3
Schentag, J.J.4
Forrest, A.5
Moellering Jr., R.C.6
-
29
-
-
34547226145
-
Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing
-
Mwangi, M. M., S. W. Wu, Y. Zhou, K. Sieradzki, H. de Lencastre, P. Richardson, D. Bruce, E. Rubin, E. Myers, E. D. Siggia, and A. Tomasz. 2007. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc. Natl. Acad. Sci. USA 104: 9451-9456.
-
(2007)
Proc. Natl. Acad. Sci. USA
, vol.104
, pp. 9451-9456
-
-
Mwangi, M.M.1
Wu, S.W.2
Zhou, Y.3
Sieradzki, K.4
De Lencastre, H.5
Richardson, P.6
Bruce, D.7
Rubin, E.8
Myers, E.9
Siggia, E.D.10
Tomasz, A.11
-
30
-
-
62449183879
-
Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
-
Rybak, M., B. Lomaestro, J. C. Rotschafer, R. Moellering, Jr., W. Craig, M. Billeter, J. R. Dalovisio, and D. P. Levine. 2009. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am. J. Health Syst. Pharm. 66:82-98.
-
(2009)
Am. J. Health Syst. Pharm.
, vol.66
, pp. 82-98
-
-
Rybak, M.1
Lomaestro, B.2
Rotschafer, J.C.3
Moellering Jr., R.4
Craig, W.5
Billeter, M.6
Dalovisio, J.R.7
Levine, D.P.8
-
31
-
-
0037443852
-
Staphylococcus aureus accessory gene regulator (agr) group II: Is there a relationship to the development of intermediate-level glycopeptide resistance?
-
Sakoulas, G., G. M. Eliopoulos, R. C. Moellering, Jr., R. P. Novick, L. Venkataraman, C. Wennersten, P. C. DeGirolami, M. J. Schwaber, and H. S. Gold. 2003. Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance? J. Infect. Dis. 187:929-938.
-
(2003)
J. Infect. Dis.
, vol.187
, pp. 929-938
-
-
Sakoulas, G.1
Eliopoulos, G.M.2
Moellering Jr., R.C.3
Novick, R.P.4
Venkataraman, L.5
Wennersten, C.6
Degirolami, P.C.7
Schwaber, M.J.8
Gold, H.S.9
-
32
-
-
0036237753
-
Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin
-
Sakoulas, G., G. M. Eliopoulos, R. C. Moellering, Jr., C. Wennersten, L. Venkataraman, R. P. Novick, and H. S. Gold. 2002. Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Antimicrob. Agents Chemother. 46: 1492-1502.
-
(2002)
Antimicrob. Agents Chemother.
, vol.46
, pp. 1492-1502
-
-
Sakoulas, G.1
Eliopoulos, G.M.2
Moellering Jr., R.C.3
Wennersten, C.4
Venkataraman, L.5
Novick, R.P.6
Gold, H.S.7
-
33
-
-
29244439618
-
Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy
-
Sakoulas, G., R. C. Moellering, Jr., and G. M. Eliopoulos. 2006. Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy. Clin. Infect. Dis. 42(Suppl. 1):S40-S50.
-
(2006)
Clin. Infect. Dis.
, vol.42
, Issue.SUPPL. 1
-
-
Sakoulas, G.1
Moellering Jr., R.C.2
Eliopoulos, G.M.3
-
34
-
-
2942558870
-
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia
-
Sakoulas, G., P. A. Moise-Broder, J. Schentag, A. Forrest, R. C. Moellering, Jr., and G. M. Eliopoulos. 2004. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J. Clin. Microbiol. 42:2398-2402.
-
(2004)
J. Clin. Microbiol.
, vol.42
, pp. 2398-2402
-
-
Sakoulas, G.1
Moise-Broder, P.A.2
Schentag, J.3
Forrest, A.4
Moellering Jr., R.C.5
Eliopoulos, G.M.6
-
35
-
-
54749134947
-
Prevalence of agr dysfunction among colonizing Staphylococcus aureus strains
-
Shopsin, B., A. Drlica-Wagner, B. Mathema, R. P. Adhikari, B. N. Kreiswirth, and R. P. Novick. 2008. Prevalence of agr dysfunction among colonizing Staphylococcus aureus strains. J. Infect. Dis. 198:1171-1174.
-
(2008)
J. Infect. Dis.
, vol.198
, pp. 1171-1174
-
-
Shopsin, B.1
Drlica-Wagner, A.2
Mathema, B.3
Adhikari, R.P.4
Kreiswirth, B.N.5
Novick, R.P.6
-
36
-
-
31944437335
-
Inhibition of the autolytic system by vancomycin causes mimicry of vancomycin-intermediate Staphylococcus aureus-type resistance, cell concentration dependence of the MIC, and antibiotic tolerance in vancomycin-susceptible S. aureus
-
DOI 10.1128/AAC.50.2.527-533.2006
-
Sieradzki, K., and A. Tomasz. 2006. Inhibition of the autolytic system by vancomycin causes mimicry of vancomycin-intermediate Staphylococcus aureus- type resistance, cell concentration dependence of the MIC, and antibiotic tolerance in vancomycin-susceptible S. aureus. Antimicrob. Agents Chemother. 50:527-533. (Pubitemid 43190962)
-
(2006)
Antimicrobial Agents and Chemotherapy
, vol.50
, Issue.2
, pp. 527-533
-
-
Sieradzki, K.1
Tomasz, A.2
-
37
-
-
29244453234
-
The role of vancomycin in the treatment paradigm
-
Stevens, D. L. 2006. The role of vancomycin in the treatment paradigm. Clin. Infect. Dis. 42(Suppl. 1):S51-S57.
-
(2006)
Clin. Infect. Dis.
, vol.42
, Issue.SUPPL. 1
-
-
Stevens, D.L.1
-
38
-
-
34249870835
-
Impact of drug-exposure intensity and duration of therapy on the emergence of Staphylococcus aureus resistance to a quinolone antimicrobial
-
Tam, V. H., A. Louie, T. R. Fritsche, M. Deziel, W. Liu, D. L. Brown, L. Deshpande, R. Leary, R. N. Jones, and G. L. Drusano. 2007. Impact of drug-exposure intensity and duration of therapy on the emergence of Staphylococcus aureus resistance to a quinolone antimicrobial. J. Infect. Dis. 195:1818-1827.
-
(2007)
J. Infect. Dis.
, vol.195
, pp. 1818-1827
-
-
Tam, V.H.1
Louie, A.2
Fritsche, T.R.3
Deziel, M.4
Liu, W.5
Brown, D.L.6
Deshpande, L.7
Leary, R.8
Jones, R.N.9
Drusano, G.L.10
-
39
-
-
33846915413
-
Pharmacokinetic/pharmacodynamic modeling of in vitro activity of azithromycin against four different bacterial strains
-
Treyaprasert, W., S. Schmidt, K. H. Rand, U. Suvanakoot, and H. Derendorf. 2007. Pharmacokinetic/pharmacodynamic modeling of in vitro activity of azithromycin against four different bacterial strains. Int. J. Antimicrob. Agents 29:263-270.
-
(2007)
Int. J. Antimicrob. Agents
, vol.29
, pp. 263-270
-
-
Treyaprasert, W.1
Schmidt, S.2
Rand, K.H.3
Suvanakoot, U.4
Derendorf, H.5
-
40
-
-
21444454242
-
Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations
-
Tsuji, B. T., and M. J. Rybak. 2005. Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob. Agents Chemother. 49:2735-2745.
-
(2005)
Antimicrob. Agents Chemother.
, vol.49
, pp. 2735-2745
-
-
Tsuji, B.T.1
Rybak, M.J.2
-
41
-
-
33847627949
-
Evaluation of accessory gene regulator (agr) group and function in the proclivity towards vancomycin intermediate resistance in Staphylococcus aureus
-
Tsuji, B. T., M. J. Rybak, K. L. Lau, and G. Sakoulas. 2007. Evaluation of accessory gene regulator (agr) group and function in the proclivity towards vancomycin intermediate resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 51:1089-1091.
-
(2007)
Antimicrob. Agents Chemother.
, vol.51
, pp. 1089-1091
-
-
Tsuji, B.T.1
Rybak, M.J.2
Lau, K.L.3
Sakoulas, G.4
-
42
-
-
42049122118
-
Attenuated vancomycin bactericidal activity against Staphylococcus aureus hemB mutants expressing the small-colony-variant phenotype
-
Tsuji, B. T., C. von Eiff, P. A. Kelchlin, A. Forrest, and P. F. Smith. 2008. Attenuated vancomycin bactericidal activity against Staphylococcus aureus hemB mutants expressing the small-colony-variant phenotype. Antimicrob. Agents Chemother. 52:1533-1537.
-
(2008)
Antimicrob. Agents Chemother.
, vol.52
, pp. 1533-1537
-
-
Tsuji, B.T.1
Von Eiff, C.2
Kelchlin, P.A.3
Forrest, A.4
Smith, P.F.5
-
43
-
-
0033697445
-
Impact of the agr quorum-sensing system on adherence to polystyrene in Staphylococcus aureus
-
Vuong, C., H. L. Saenz, F. Gotz, and M. Otto. 2000. Impact of the agr quorum-sensing system on adherence to polystyrene in Staphylococcus aureus. J. Infect. Dis. 182:1688-1693.
-
(2000)
J. Infect. Dis.
, vol.182
, pp. 1688-1693
-
-
Vuong, C.1
Saenz, H.L.2
Gotz, F.3
Otto, M.4
|